Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Chemical modification or the reaction product thereof – e.g.,...
Patent
1995-06-07
1998-03-31
Cunningham, Thomas M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Chemical modification or the reaction product thereof, e.g.,...
4241851, 4241931, 530300, 530395, 530402, 530868, C07K 1474, C07K 1700, A61K 39385
Patent
active
057340234
ABSTRACT:
The present invention is directed to complexes comprising an isolated MHC subunit component, an antigenic peptide and, in some cases, an effector component. The antigenic peptide is associated with the antigen binding site of the MHC subunit component. These complexes are useful in treating autoimmune disease.
REFERENCES:
patent: 4400376 (1983-08-01), Sanderson
patent: 4478823 (1984-10-01), Sanderson
patent: 5130297 (1992-07-01), Sharma et al.
patent: 5194425 (1993-03-01), Sharma et al.
Rothenhausler, B., et al., "Specific binding of antigenic molecules of the major histocompatiblity complex" Proc. Natl. Acad. Sci. USA, 87:352-354 (1990).
Harding, Clifford V. and Unaune, Emil R., "Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation", Nature, 346:574-576 (1990).
Brown, J.H., et al., "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1", Nature, 364:33-39 (1993).
Newsome-Davis, et al., "T-Cell Reactivity in Myasthenia Gravis" Journal of Autoimmunity, 2:101-108 (1989).
Hansen, et al., "The Major Histocompatibility Complex" Fundamental Immunology, 3d Ed., W. Paul, pp. 617-620 (1993).
Grey, H.M. et al., "How T Cells See Antigen", Scientific American, 56-64 (1989).
Buus, S. et al., "Autologous Peptides Constitutively Occupy the Antigen Binding Site on Ia", Science, 242:1045-1047 (1988).
Demotz et al., "Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme", Nature, 342:682-684 (1989).
Sinha et al., "Autoimmune Disease: The Failure of Self Tolerance", Science, 248:1380-1387 (1990).
Shizuru, J.A. et al., "Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper LlLymphocytes", Science, 240:659-662 (1988).
Schwartz, "Acquisition of Immunologic Self-Tolerance", Cell, 1073-1081 (1989).
Quill et al., "Stimulation of Normal Inducer T Cell Clones With Antigen Presented By Purified Ia Molecules in Planar Lipid membranes: Specific Induction of a Long-Lived State of Proliferative Nonresponsiveness", J. Immunol., 138:3704-3712 (1987).
O'Hehir, et al., "The Specificity and Regulation of T-Cell Responsiveness to Allergens", Ann. Rev. Immunol., 9:67-95 (1991).
Passmore, David et al., "Preparative-scale purification and characterization of MHC class II monomers", J. Immunol., 155:193-200 (1992).
Buus, S. et al., "The relation between Major Histocompatibility Complex (MHC) restriction and the Capacity of Ia to bind immunogenic peptides" Science, 235:1353-1358 (1987).
Bjorkman, et al., "Structure of the human class I histocompatibility antigen, HLA-A2", Nature, 329:512-518 (1987).
Bjorkman, P.J. et al., "The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens" Nature, 329:512-518 (1987).
Marguiles, D.H. et al, "Engineering soluble major histocompatibility molecules: Why and how", Immunological Research, 6:101-116 (1987).
Marx, J.L., "Structure of MHC protein solved", Science, 329:613-614 (1987).
Townsend, A. et al., "Those images that yet fresh images beget" Nature, 329:482-483 (1987).
Nag, Bishwajit et al., Stimulation of T Cells by antigenic peptide complexed with complex class II molecules, Proc. Natl. Acad. Sci. USA, Immunology, 90:1604-1608 (1993).
Luescher, I.F., et al., "The Sites in the I-A.sup.k Histocompatibility Molecule Photoaffinity Labeled by an Immunogenic Lysozyme Peptide," The American Society of Biochemistry and Molecular Biology, Inc., vol. 265, No. 19, pp. 11177-11184.
Wraith, D.C., et al., "Antigen Recognition in Autoimmune Encephalomyelitis and the Potential for Peptide-Mediated Immunotherapy," Cell, vol. 59, pp. 247-255 (Oct. 20, 1989).
McCluskey, J., et al. "Cell Surface Expression of an In Vitro Recombinant Class II/Class I Major Histocompatibility Complex Gene Product" Cell, 40:247-257 (1985).
Martin, R., et al. "A Myelin Basic Protein Peptide is Recognized by Cytotoxic T Cells in the Context of Four HLA-DR Types Associated with Multiple Sclerosis" The Journal of Experimental Medicine, 173:19-24 (1991).
Ota, K., et al., "T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis", Nature, 346:183-1187 (1990).
Weaver, Casey T. and Unanue, Emil R., "The costimulatory function of antigen-presenting cells," Immunology Today, 11:49-55 (1990).
Golding, H., et al., "T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4", Nature, 317:425-427 (1985).
Parce, J., et al., "Detection of Cell-Affecting Agents with a Silicon Biosensor", Science, 246:243-247 (1989).
Owicki, J.C., et al., "Continuous Monitoring of receptor-mediated changes in the metabolic rates of living cells" Proc. Natl. Acad. Sci. USA, 87:4007-4001 (1990).
Dornmair, K., et al., "In vitro peptide binding to the heavy chain of the class I molecule of the major histocompatibility complex molecule HLA-A2" Proc. Natl. Acad. Sci. USA, 88:1335-1338 (1991).
Sharma, S.D. et al., "Antigen-specific therapy experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes", Proc. Natl. Acad. Sci. USA, Immunology, 88:11465-11469 (1991).
Nag, Bishwajit et al., "Functionally Active Recombinant .alpha. and .beta. Chain-Peptide Complexes of Human Major Histocompatibility Class II Molecules", Journal of Biological Chemistry, 271:10413-10418 (1996).
Arimilli, Subhashini et al. "Refolding and Reconstitution of Functionally Active Complexes of' Human Leukocyte Antigen DR2 and Myelin Basic Protein Peptide from Recombinant .alpha. and .beta. Polypeptide Chains", Journal of Biological Chemistry, 270:971-977, (1995).
Bishwajit, Nag et al., "Intramolecular Charge Heterogeneity in Purified Major Histocompatibility Class II .alpha. and .beta. Polypeptide Chains", Journal of Biological Chemistry, 269:10061-10070, (1994).
Topham, David J. et al., "A synthetic peptide from the third hypervariable region of major histocompatibility complex class II .beta. chain as a vaccine for treatment of experimental autoimmune encephalomyelitis", Proc. Natl. Acad. Sci. USA, 91:8005-8009, (1994).
Hodes, Richard J. and Terry, William D., "Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization", Journal of Immunology, vol. 113 (1974).
Clark Brian R.
McConnell Harden
Nag Bishwajit
Sharma Somesh
Anergen Inc.
Cunningham Thomas M.
LandOfFree
MHC class II .beta. chain/peptide complexes useful in ameliorati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MHC class II .beta. chain/peptide complexes useful in ameliorati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MHC class II .beta. chain/peptide complexes useful in ameliorati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-53248